Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1599298 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $13.44Day +5.00%Mkt cap $10.7B1Y −49.6%Off 52W high −56.6%Vol (1Y) 73.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,587 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.7% of sh out |
| Days to cover11.0d |
| 13F net flow (QoQ)−0.14% |
| Top-10 13F concentration77.7% |
| Next report (est.)2026-10-16 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$856.1M |
| ROE−206.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−23.2% |
| 1Y−49.6% |
| 3Y+540.0% |
| 5Y+83.4% |
| Since incept. (ann.)+32.0% |
Total return through 2026-07-30 · series begins 2020-04-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)73.8% |
| Ann. volatility (3Y)187.6% |
| Sharpe (1Y)−0.56 |
| Sharpe (3Y)0.86 |
| Max drawdown (1Y)−57.2% |
| Max drawdown (3Y)−65.8% |
| Beta (3Y vs SPY)1.19 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 36.4M | $690M | 4.69% | +0.0% |
| FMR LLC | 10.9M | $206M | 1.40% | −18.8% |
| BlackRock, Inc. | 9.7M | $183M | 1.25% | +3.1% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8.3M | $157M | 1.07% | −11.7% |
| STATE STREET CORP | 7.0M | $133M | 0.91% | +5.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | $108M | 0.74% | new |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.2M | $99M | 0.67% | new |
| UBS Group AG | 3.7M | $70M | 0.47% | +322.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-06-30 | 2026-07-23 | −$0.28 | — | — | — |
| 2026-03-31 | 2026-04-30 | −$0.24 | — | — | — |
| 2025-09-30 | 2025-10-20 | −$0.31 | — | — | — |
| 2025-06-30 | 2025-08-11 | −$0.76 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-16 is ESTIMATED from filing cadence (median gap 85d) — not company-confirmed.
